Ernexa Therapeutics (ERNA) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Ernexa Therapeutics (ERNA) over the last 14 years, with Q4 2024 value amounting to $172000.0.
- Ernexa Therapeutics' Accumulated Depreciation & Amortization rose 5087.72% to $172000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $172000.0, marking a year-over-year increase of 5087.72%. This contributed to the annual value of $172000.0 for FY2024, which is 5087.72% up from last year.
- According to the latest figures from Q4 2024, Ernexa Therapeutics' Accumulated Depreciation & Amortization is $172000.0, which was up 5087.72% from $114000.0 recorded in Q4 2023.
- Ernexa Therapeutics' 5-year Accumulated Depreciation & Amortization high stood at $433000.0 for Q2 2020, and its period low was $32000.0 during Q4 2022.
- In the last 5 years, Ernexa Therapeutics' Accumulated Depreciation & Amortization had a median value of $132700.0 in 2020 and averaged $169400.0.
- In the last 5 years, Ernexa Therapeutics' Accumulated Depreciation & Amortization crashed by 9869.18% in 2020 and then surged by 25625.0% in 2023.
- Over the past 5 years, Ernexa Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $120000.0 in 2020, then rose by 21.17% to $145400.0 in 2021, then tumbled by 77.99% to $32000.0 in 2022, then soared by 256.25% to $114000.0 in 2023, then skyrocketed by 50.88% to $172000.0 in 2024.
- Its Accumulated Depreciation & Amortization was $172000.0 in Q4 2024, compared to $114000.0 in Q4 2023 and $32000.0 in Q4 2022.